Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is The Pain Over For Illumina?
Seeking Alpha
Sunday, October 9, 2011 - 3:41pm
tags:
Illumina
Siga Seeks Another Lawsuit Look
Seeking Alpha
Sunday, October 9, 2011 - 3:40pm
tags:
SIGA technologies, PharmAthene, ST-246
Suit accuses pharma companies of Medicaid price-data manipulation
Philly.com
Saturday, October 8, 2011 - 12:51pm
tags:
Upsher-Smith, Sunovion, Reliant, NovoNordisk, Medicaid fraud, Mallinckrodt, legal, Genzyme, Eisai, Cephalon, Bradley, Biogen, AstraZeneca, Amgen, Allergan
FDA Approves Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
PR NewsWire
Saturday, October 8, 2011 - 12:45pm
tags:
Combivent Respimat, COPD, Boehringer Ingelheim
Jury Orders Teva, Baxter, McKesson to Pay $20M in Hep C Case
Becker's ASC Review
Saturday, October 8, 2011 - 12:43pm
tags:
Teva Pharmaceuticals, Baxter, McKesson, hepatitis C, legal
BioAdvance’s ROI tops $11 million
bizjournals
Saturday, October 8, 2011 - 12:40pm
tags:
BioAdvance
Bulls Deem Eli Lilly Calls To Be the Right Option Medicine
Schaeffer's
Saturday, October 8, 2011 - 12:40pm
tags:
Eli Lilly
BioMarin Stock Hits New 52-Week High
The Street
Saturday, October 8, 2011 - 12:38pm
tags:
Biomarin
Top guns of big pharma vie for India pie
MoneyControl
Saturday, October 8, 2011 - 12:38pm
tags:
India
I am a strong fan of India, says Sanofi-Aventis' CEO
MoneyControl
Saturday, October 8, 2011 - 12:37pm
tags:
Sanofi, India
Is Eli Lilly's Stock Cheap by the Numbers?
Motley Fool
Saturday, October 8, 2011 - 12:35pm
tags:
Eli Lilly
A Little Help, Please (Gilead Sciences)
Motley Fool
Saturday, October 8, 2011 - 12:35pm
tags:
Gilead Sciences, Boehringer Ingelheim, HIV, Complera, Quad, BI 224436
Update on Sanofi's Multaq
Yahoo/Zacks
Saturday, October 8, 2011 - 12:32pm
tags:
Sanofi, Multaq, arrhythmia
Pfizer Trading at an Undeserved Discount: Analyst
Barron's
Saturday, October 8, 2011 - 11:57am
tags:
Pfizer
Generic Threat for Warner Chilcott
Yahoo/Zacks
Saturday, October 8, 2011 - 11:56am
tags:
Warner Chilcott, Asacol HD, Zydus, generics, legal, ulcerative colitis
Pfizer Stops Epilepsy Drug Trial as Efficacy Proved
Bloomberg
Saturday, October 8, 2011 - 11:55am
tags:
Pfizer, Lyrica, epilepsy
Large-Cap Global Pharma Stocks May Provide Appreciation and Income
Seeking Alpha
Saturday, October 8, 2011 - 11:53am
tags:
AstraZeneca, Merck, Bristol-Myers Squibb, GSK, Eli Lilly, Pfizer, Sanofi
Teva Agrees to Conditions for Drug Merger (with Cephalon)
NY Times
Saturday, October 8, 2011 - 11:51am
tags:
Teva Pharmaceuticals, Cephalon, M&A
Poniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNE
Yahoo/MarketWire
Saturday, October 8, 2011 - 11:50am
tags:
Poniard, M&A, Allozyne
Momenta Pharmaceuticals Obtains Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.
Yahoo/GlobeNewswire
Saturday, October 8, 2011 - 11:48am
tags:
Momenta, Watson Pharmaceuticals, Amphastar, enoxaparin, legal, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.